News
CordenPharma leases space at Flatiron Park for peptides development
19+ hour, 1+ min ago (220+ words) CordenPharma Colorado will occupy the 5505 Central building under a 15-year lease. US-based CordenPharma Colorado has leased a 64,000ft" space at BioMed Realty's Flatiron Park's 5505 Central, which marks Boulder's first purpose-built speculative lab building, for peptides development. CordenPharma Colorado will occupy the…...
Sanofi bets on Sino Biopharm’s transplant drug in $1.5bn licensing deal
1+ day, 11+ hour ago (347+ words) By blocking the JAK and ROCK pathways, rovadicitinib offers a differentiated mechanism of action to best-selling, single-target GVHD drugs like Jakavi and Imbruvica. As part of this deal, Sanofi will pay $135m upfront for the global development, manufacturing and commercialisation rights…...
Esperion to acquire Corstasis for cardiovascular franchise expansion
1+ day, 19+ hour ago (314+ words) Esperion Therapeutics has signed a definitive agreement to acquire Corstasis Therapeutics to expand its cardiovascular franchise with the addition of Enbumyst, a bumetanide nasal spray. Enbumyst is approved by the US Food and Drug Administration (FDA) for treating oedema linked…...
Pharma rings the changes as CEO shake-up continues
2+ day, 12+ hour ago (574+ words) While some chief executives have left for personal reasons, others have been ousted amid poor company performance. Bavarian Nordic's announcement that Paul Chaplin will step down as CEO has marked the latest high-profile change at a pharmaceutical company in 2026. Chaplin,…...
Novo Nordisk starts €432m Ireland facility upgrade for oral Wegovy production
2+ day, 13+ hour ago (260+ words) Both Novo and obesity market rival Eli Lilly have outlaid significant funds to ensure future demand for oral weight loss drugs is met. Novo Nordisk has invested "432m ($501m) to upgrade its facility in Ireland to ensure the drugmaker can meet the…...
Europe’s pharma trade with the US remains critical despite tariff turmoil
2+ day, 13+ hour ago (902+ words) New drugs and lucrative markets in the US remain crucial to Europe's pharma sector, as governments approach closer trade with Asia. US government policies of Most Favored Nation (MFN) and tariffs threaten to disrupt Europe's pharmaceutical trade, but while European…...
Kairos Pharma signs deal for Celyn Therapeutics’ CL-273
2+ day, 14+ hour ago (221+ words) The acquisition aims to accelerate the development of targeted therapies for EGFR mutant NSCLC patients globally. Kairos Pharma has signed a binding agreement to acquire exclusive worldwide rights to CL-273 from Celyn Therapeutics, a company backed by OrbiMed and Torrey Pines…...
Slate Medicines raises $130m funding to progress anti-PACAP treatments
1+ week, 1+ day ago (302+ words) The funding aligns with the in-licensing of SLTE-1009, an anti-PACAP monoclonal antibody acquired from DartsBio Pharmaceuticals. The company is headed by CEO and board director Gregory Oakes, who brings more than 30 years of experience from clinical-stage and commercial biopharma organisations....
Novo Nordisk flags board members for re-election amid restructuring efforts
1+ week, 3+ day ago (322+ words) Three new board and shareholder-elected members could join Novo's council, which largely consists of recent appointees following a restructure in October 2025. In a bid to'regain operational stability, Novo Nordisk's Board of Directors has nominated'two new members to join the'committee, which…...
Ex-Trump official-ran Altesa secures $75m in Series B funding round
1+ week, 6+ day ago (324+ words) The biotech, which is co-run by ex US Health Secretary Brett Giroir, will progress its COPD-centric anti-rhinoviral therapy to mid-stage trials. Altesa BioSciences has closed an oversubscribed $75m Series B funding round to advance the clinical development of its antiviral, vapendavir....